Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by P. Lapuerta
Cost-Effectiveness of Early Irbesartan Treatment Versus Control (Standard Antihypertensive Medications Excluding ACE Inhibitors, Other Angiotensin-2 Receptor Antagonists, and Dihydropyridine Calcium Channel Blockers) or Late Irbesartan Treatment in Patients With Type 2 Diabetes, Hypertension, and Renal Disease
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Related publications
Combination Therapy With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Antagonists in the Treatment of Patients With Type 2 Diabetes Mellitus
Archives of Internal Medicine
Effect of Irbesartan Treatment on Plasma and Urinary Markers of Protein Damage in Patients With Type 2 Diabetes and Microalbuminuria
Amino Acids
Organic Chemistry
Biochemistry
Clinical Biochemistry
Severe Acute Respiratory Syndrome Coronavirus 2 Infection, Angiotensin-Converting Enzyme 2 and Treatment With Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Type 1 Receptor Blockers
European Journal of Preventive Cardiology
Epidemiology
Cardiovascular Medicine
Cardiology
The Impact of ACE Inhibitors or Angiotensin II Type 1 Receptor Blockers on the Development of New-Onset Type 2 Diabetes
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Efficiency Assessment for Antihypertensive, Hemodynamic, Renal Effects of Adenosine-Converting Enzyme (ACE) Inhibitors and Irbesartan and Impact on Endothelial Disfunction in Patients With Stage II Hypertension
Zaporozhye Medical Journal
Maximising Antihypertensive Effects of Angiotensin II Receptor Blockers With Thiazide Diuretic Combination Therapy: Focus on Irbesartan/Hydrochlorothiazide
International Journal of Clinical Practice
Medicine
Endothelial Effects of Antihypertensive Treatment: Focus on Irbesartan
Vascular Health and Risk Management
Organoprotecive Effects of Angiotensin II Receptor Blockers in Patients With Type 2 Diabetes Mellitus
Diabetes Mellitus
Internal Medicine
Endocrinology
Metabolism
Diabetes
Comparative Analysis of the Anticancer Activity of Angiotensin Receptor Blockers - Irbesartan and Telmisartan
Asian Journal of Pharmaceutical and Clinical Research
Pharmacology
Pharmaceutical Science